Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease. A preliminary analysis ...

Key points A 40-year-old man was referred to our internal medicine clinic for assessment of a 3-month history of unintentional weight loss and daily night sweats with subjective fevers. He had been ...

Turmeric fights inflammation, while magnesium aids sleep and mental health. Can you take them together? Discover the benefits ...

ABIVAX is a French biotech with a novel ulcerative colitis treatment in phase 3 trials. Click here to find out why I am ...

CRANBURY, NJ, USA I March 28, 2025 I Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Vitamin B is a group of water-soluble vitamins essential for energy production, brain function, and red blood cell formation.

Medically reviewed by Sohaib Imtiaz, MD Magnesium is an essential mineral that is involved in more than 300 body processes, ...

Whenever gluten is consumed in people with celiac disease, the immune system will view the protein as harmful and launch an inflammatory attack, damaging villi. Crohn's disease is a type ... When ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease ... may reduce disease symptoms and improve quality of life in patients with inflammatory bowel ...

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a first-of-its-kind study. Early treatment of pediatric Crohn's disease ...

A pioneering clinical trial backed by the EU and drugmaker Takeda will look for biomarkers that could be used to identify people at risk of developing Crohn's disease in the hope of intervening ...